In an orthotopic model of ovarian carcinoma, treatment with chitosan NPs carrying siRNAs targeting human EZH2 (expressed in the transplanted cancer cells) or murine EZH2 (expressed in the endogenous murine vasculature) inhibited tumor growth. The gene discussed is EZH2; the disease is neoplasm.